HR-2376 : Still Just a Bill

Prescription Pricing for the People Act of 2019

This bill directs the Federal Trade Commission to report to Congress on the effect of certain anticompetitive practices in the pharmaceutical supply chain.

Action Timeline

Action DateTypeTextSource
2019-05-21CommitteeSubcommittee Hearings Held.House committee actions
2019-04-30CommitteeReferred to the Subcommittee on Consumer Protection and Commerce.House committee actions
2019-04-30CommitteeOrdered to be Reported by Voice Vote.House committee actions
2019-04-30CommitteeCommittee Consideration and Mark-up Session Held.House committee actions
2019-04-30CommitteeReferred to the Subcommittee on Health.House committee actions
2019-04-29IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2019-04-29IntroReferralReferred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.House floor actions
2019-04-29IntroReferralIntroduced in HouseLibrary of Congress

Policy Area :

Commerce
See Subjects
  • Business ethics
  • Business records
  • Competition and antitrust
  • Congressional oversight
  • Consumer affairs
  • Health care costs and insurance
  • Health information and medical records
  • Inflation and prices
  • Prescription drugs
  • Retail and wholesale trades

Related Bills

See Related Bills